Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Democrats, Republicans using health reform votes to plot November strategies

The Associated Press: Vulnerable Democrats around the country are "tiptoeing" during the recess as they prepare for midterm elections. "Tough votes for Obama's health care plan have further complicated the re-election prospects of dozens of already vulnerable freshman and second-term Democrats. There's even a chance the party could lose control of one or both houses in the midterm elections."

9 Apr 2010

Study: 75% of men with diabetes will develop some degree of ED

Erectile dysfunction is one of the most prevalent diabetes-induced complications in men; current estimates suggest that as many as 75% of men with diabetes will develop some degree of ED, and in many cases diabetics develop more severe forms of ED that are less responsive to standard drugs.

7 Apr 2010

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.

2 Apr 2010

VIVUS terminates Luramist development, commercialization agreement with FemPharm

VIVUS, Inc. today announced that it has terminated the Development and Commercialization Agreement with FemPharm Pty Ltd. (a wholly owned subsidiary of Acrux Limited) for Luramist™, a metered dose transdermal application of testosterone for women.

1 Apr 2010

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Former England Rugby World Cup winner Matt Dawson today launched the 'Because Life is for Living' campaign to raise awareness about brachytherapy, a very precise and highly effective form of radiotherapy to treat cancer.

30 Mar 2010

FDA Advisory Committee to review VIVUS' NDA for Qnexa

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration is tentatively scheduled to review the Company's New Drug Application for Qnexa® for the treatment of obesity on July 15, 2010.

26 Mar 2010

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.

26 Mar 2010

Senate passes health reform reconciliation bill, sends it back to House

The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.

26 Mar 2010

It's over: House passes last piece of landmark health reform, 220-207

Politico: "Congress completed its work Thursday night on the broadest social legislation in almost a half-century, as the House capped the year-long legislative saga over health reform by signing off on a package of fixes to the newly minted law. In the end, the titanic battle over remaking the American health care system drew to a close on a pair of votes drained of suspense - after the Senate approved the clean-up bill earlier Thursday. The House approved the clean-up bill, 220 to 207" (Budoff Brown, 3/25).

26 Mar 2010

Beaumont Hospital opens women's urology center

It’s something that women don’t talk about even to their best friends or their doctors. That’s why Beaumont Hospitals has created a new Women’s Urology Center offering leading-edge treatments, innovative research and the most advanced minimally invasive procedures for women’s urological conditions such as incontinence, pelvic pain and sexual dysfunction.

25 Mar 2010

Senate starts debate clock on contentious health reform reconciliation bill

The Senate has begun debate, which Democrats hope to bring to a quick close, on a health care reform reconciliation bill that "fixes" parts of the law President Obama signed Tuesday.

25 Mar 2010

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

25 Mar 2010

Democrats expect to end debate early on health reconciliation bill

Senate Democratic leaders are trying to end the debate on a bill that "fixes" the health overhaul law that President Barack Obama signed Tuesday. Once the debate ends, the Senate is expected to begin voting on a number of Republican amendments, The New York Times reports.

24 Mar 2010

EHSI closes funding agreement with Celulas Genetica

Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.

22 Mar 2010

Research data: WTC collapse caused potentially dangerous heart problems in responders on-site

Researchers from Mount Sinai School of Medicine are presenting more than 20 ground-breaking studies at the American College of Cardiology 59th annual scientific session (ACC.10) in Atlanta. Their research includes data showing that the World Trade Center collapse has caused potentially dangerous heart problems in responders on-site.

17 Mar 2010

BeaconEquity.com announces investment report featuring NexMed

BeaconEquity.com announces an investment report featuring NexMed Inc. (Nasdaq:NEXM). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

12 Mar 2010

Watson Pharmaceuticals' TRELSTAR receives FDA approval for treatment of advanced prostate cancer

Watson Pharmaceuticals, Inc., today announced the U.S. Food and Drug Administration approval of TRELSTAR® 22.5 mg (triptorelin pamoate for injectable suspension), a new twice-yearly formulation of TRELSTAR®, a proven, simple and effective palliative treatment of advanced prostate cancer.

11 Mar 2010

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

New research published in today's issue of the Archives of Internal Medicine (Vol. 170, No. 5), by an investigator at The Cancer Institute of New Jersey and colleagues at Memorial Sloan-Kettering Cancer Center in New York, shows that the type of specialist that men with localized prostate cancer see can influence the form of therapy they ultimately receive.

9 Mar 2010

VIVUS granted three additional patents for Qnexa

VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.

8 Mar 2010

Zoraxel for treatment of ED: Rexahn Pharmaceuticals submits Phase IIb protocol to FDA

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction (ED).

4 Mar 2010

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Democrats, Republicans using health reform votes to plot November strategies

Study: 75% of men with diabetes will develop some degree of ED

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

VIVUS terminates Luramist development, commercialization agreement with FemPharm

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

FDA Advisory Committee to review VIVUS' NDA for Qnexa

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Senate passes health reform reconciliation bill, sends it back to House

It's over: House passes last piece of landmark health reform, 220-207

Beaumont Hospital opens women's urology center

Senate starts debate clock on contentious health reform reconciliation bill

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Democrats expect to end debate early on health reconciliation bill

EHSI closes funding agreement with Celulas Genetica

Research data: WTC collapse caused potentially dangerous heart problems in responders on-site

BeaconEquity.com announces investment report featuring NexMed

Watson Pharmaceuticals' TRELSTAR receives FDA approval for treatment of advanced prostate cancer

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

VIVUS granted three additional patents for Qnexa

Zoraxel for treatment of ED: Rexahn Pharmaceuticals submits Phase IIb protocol to FDA

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in